← Maze Therapeutics (MAZE)

Maze Therapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 8-KOct. 16, 2026, 4:05 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Unregistered sales of equity securities · Financial statements and exhibits

  • 8-KAug. 17, 2026, 4:16 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits

  • 8-KAug. 11, 2026, 4:45 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits